Atom Investors LP Protagonist Therapeutics, Inc Transaction History

Atom Investors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$7.06 - $25.52 $72,986 - $263,825	10,338 New	10,338 $82,000
Q2 2021 Aug 16, 2021	SELL	$25.57 - $44.88 $780,958 - $1.37 Million	-30,542 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$19.02 - $31.15 $1.32 Million - $2.16 Million	-69,277 Reduced 69.4%	30,542 $791,000
Q4 2020 Feb 16, 2021	BUY	$18.49 - $25.13 $1.64 Million - $2.22 Million	88,473 Added 779.77%	99,819 $2.01 Million
Q3 2020 Nov 13, 2020	BUY	$15.19 - $22.4 $172,345 - $254,150	11,346 New	11,346 $222,000

248

56.7M

76.3K

114K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $1.93B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.